Biologics Market Global Briefing 2018Including: Therapeutic Proteins, Monoclonal Antibodies (MAbS), Vaccines.Covering: Amgen, AbbVie, Johnson & Johnson, Bristol-Myers Squibb Company, Pfizer, Eli Lilly, F. Hoffmann-La Roche Ltd, Merck & Co., GlaxosmithKline, Sanofi
North America was the largest region in the biologics market in 2017, accounting for around 40% market share. This can be attributed to the high per capita healthcare expenditure in the region and the investment in novel treatments leading to the early adoption of new anti-inflammatory, anti-cancer and anti-viral biologics in the region. Western Europe was the second largest region accounting for around 23% market share. Asia Pacific was the third largest region accounting for around 16% market share.
Biologics Market Global Briefing 2018 provides strategists, marketers and senior management with the critical information they need to assess the global biologics sector.
Reasons to Purchase
Fully updated for 2018.
Identify growth segments and opportunities.
Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
Develop strategies based on likely future developments.
Gain a global perspective on the development of the market.
Biologics Market Global Briefing 2018 from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.
The market characteristics section of the report defines and explains the market.
The market size section gives the biologics market revenues, covering both the historic growth of the market and forecasting the future.
Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.
Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.
The trends and strategies section highlights the likely future developments in the biologics market and suggests approaches.